Page 270 - Livre électronique du congrès AFMAPATH 2024

P172. THE USE OF TRADITIONAL MOROCCAN MEDICINE IN
PATIENTS WITH LUNG CANCER

N. BOUTBAGHA, S. FARHAT, H. IKROU, S. ABDALA, H. SERHANE

PNEUMOLOGY DEPARTMENT, CHR HASSAN II, CHU SOUSS-MASSA, FMPA, UNIVERSITY IBN ZOHR
- AGADIR (MOROCCO)

Introduction:

Worldwide, cancer is the second leading cause of death, with major socio-economic
consequences. Which is why early diagnosis and appropriate treatment are so important.

The aim of our study is to identify the prevalence of traditional medicine use among patients
diagnosed with lung cancer.

Methods:

We prospectively followed 92 patients diagnosed with lung cancer in the pneumology
department of HASSAN II Hospital in Agadir from September 2023 to January 2024.

Results:

The mean age was 62,15 ± 8,57 years with a male predominance (91,3%). 93,7% were smokers with

an average consumption of 38. Comorbidities were present in 81,5% of cases dominated by:
diabetes 22,8%, cardiopathy 17,4%, pulmonary hypertension 13% and pneumothorax 11%.

Diagnosis was confirmed by: pleural biopsy (68,3%), CT-guided biopsy (20,4%), endobronchial
biopsy (9,8%) and lymph node biopsy in 1,5% of cases. Histological type was distributed as
follows: adenocarcinoma in 70%, squamous cell carcinoma in 24,6% and small cell carcinoma in
3,6% of cases.

Most of our patients had received palliative treatment in 46,4%, although chemotherapy was
proposed in 39,9% and surgery in 12% of cases.

61,5% of patients added traditional medicine to cure the disease, the most commonly used
substances were: pure honey, herbs (ginseng, fenugreek, thyme, rosemary…), spices (turmeric,
cumin, cinnamon…), others (garlic, olive oil, fig, date…). Religious practices were used by 32% of
patients.

Conclusion:

Cancer is a major public health problem, complementary medicine must be the subject of
scientific studies to assess their potential benefits, toxicities and interactions with conventional
treatments.

269 | P a ge